← Retour au Screener

Sector: Santé
Open in Terminal → REG1V.HELive chart · Key metrics · News · Smart money

Revenio Group

REG1V.HE Small Cap

Healthcare · Medical Devices

Mis à jour: Jun 18, 2026, 22:21 UTC

12,52 €
-1.26% aujourd'hui
52W: 12,34 € – 29,10 €
52W Low: 12,34 € Position: 1.1% 52W High: 29,10 €

Price Chart

Indicateurs clés

P/E Ratio
21.22x
Cours/Bénéfice
Forward P/E
12.89x
P/E prévisionnel
P/S Ratio
3.28x
Cours/Ventes
EV/EBITDA
13.73x
Valeur d'entreprise/EBITDA
Rend. dividende
3.19%
Rendement annuel du dividende
Cap. boursière
318 M €
Capitalisation boursière
Croissance du CA
4.6%
Croissance du CA sur un an
Marge bénéficiaire
14.15%
Marge nette
ROE
13.7%
Rentabilité des capitaux propres
Beta
0.84
Sensibilité au marché
Positions vendeuses
% du flottant vendu à découvert
Volume moyen
71,059
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
4 analysts
Avg. Price Target
19,38 €
+54.75% upside
Target Range
15,00 € – 23,50 €

About the Company

Sector: Healthcare Industry: Medical Devices Country: Finland Employees: 246 Exchange: HEL

Revenio Group en bref

Revenio Group (REG1V.HE) is currently trading at 12,52 € with a market capitalization of 318 M €. The trailing P/E ratio stands at 21.22x, with a forward P/E of 12.89x. The 52-week range spans from 12,34 € to 29,10 €; the current price is 57% below the yearly high. Year-over-year revenue growth stands at +4.6%. The net profit margin stands at 14.15%.

💰 Dividende

Revenio Group pays an annual dividend of 0,40 € per share, representing a yield of 3.19%. The payout ratio stands at 67.85%.

📊 Avis des analystes

4 analystes évaluent Revenio Group (REG1V.HE) au consensus : None. L'objectif de cours moyen est de 19,38 €, soit un potentiel de +54.75% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 15,00 € à 23,50 €.

Revenio Group : la thèse d'investissement en détail

Revenio Group (REG1V.HE) operates in the Healthcare — specifically Medical Devices — and is headquartered in Finland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 69.94%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

Le scénario baissier

Revenue growth has slowed to just 4.6%, which is below nominal GDP — the business is no longer outgrowing the broader economy.

Valorisation en contexte

At a PEG of 6.37, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.

À surveiller

  • The forward P/E of 12.89x is meaningfully below the trailing 21.22x — analysts expect earnings to step up; the next earnings release is the test.
  • The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
  • The dividend yield near 3.19% combined with a payout ratio of 67.85% leaves room for further hikes — a track record of consecutive raises is a strong income signal.
  • The analyst consensus price target implies 54.75% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Marge brute élevée de 69.94% — signe d'un pouvoir de fixation des prix
  • Rendement du dividende solide de 3.19%
  • Bilan solide avec faible endettement (D/E 9.21)
  • Free cash flow positif
Points faibles

Aucun signal d'alerte significatif dans les indicateurs actuels.

Aperçu technique

MM 50 jours
14,71 €
-14.89% vs. cours
MM 200 jours
19,85 €
-36.93% vs. cours
Sous le plus haut 52s
−57%
29,10 €
Au-dessus du plus bas 52s
+1.5%
12,34 €

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

Risque de marché (Bêta)
0.84 · Proche du marché
Évolue moins que le marché global
Dette/Capitaux propres
9.21 · Faible
Dette totale / capitaux propres

The data points to relatively defensive market behavior.

Trading Data

50-Day MA: 14,71 €
200-Day MA: 19,85 €
Volume: 58,175
Avg. Volume: 71,059
Short Ratio:
P/B Ratio: 2.9x
Debt/Equity: 9.21x
Free Cash Flow: 12 M €

💵 Dividend Info

Dividend Yield
3.19%
Annual Rate
0,40 €
Payout Ratio
67.85%

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Revenio Group?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut